![Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition | Nature Medicine Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-01775-6/MediaObjects/41591_2022_1775_Fig1_HTML.png)
Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition | Nature Medicine
![From Patient Focus Drug to Development to a Patient Reported Outcome: Developing PROs for Clinical Trials | PPT From Patient Focus Drug to Development to a Patient Reported Outcome: Developing PROs for Clinical Trials | PPT](https://image.slidesharecdn.com/campbellnaafmarch2017-170312221633/85/from-patient-focus-drug-to-development-to-a-patient-reported-outcome-developing-pros-for-clinical-trials-4-320.jpg?cb=1667338678)
From Patient Focus Drug to Development to a Patient Reported Outcome: Developing PROs for Clinical Trials | PPT
![Patient-reported outcomes: A primer for plastic surgeons - Journal of Plastic, Reconstructive & Aesthetic Surgery Patient-reported outcomes: A primer for plastic surgeons - Journal of Plastic, Reconstructive & Aesthetic Surgery](https://www.jprasurg.com/cms/asset/27dbe7ff-7db8-4192-9fb1-3b897014dc75/gr1.jpg)
Patient-reported outcomes: A primer for plastic surgeons - Journal of Plastic, Reconstructive & Aesthetic Surgery
![Framework and guidance for implementing patient-reported outcomes in clinical practice: evidence, challenges and opportunities Framework and guidance for implementing patient-reported outcomes in clinical practice: evidence, challenges and opportunities](https://becarispublishing.com/cms/10.2217/cer-2015-0014/asset/355f882b-acfe-4c43-9836-e13c8cff8a5e/assets/images/large/figure1.jpg)
Framework and guidance for implementing patient-reported outcomes in clinical practice: evidence, challenges and opportunities
![Approach to patient reported outcome measures selection and implementation in a chronic norovirus clinical efficacy trial for patients after solid organ transplant - Keefer - 2023 - Transplant Infectious Disease - Wiley Online Library Approach to patient reported outcome measures selection and implementation in a chronic norovirus clinical efficacy trial for patients after solid organ transplant - Keefer - 2023 - Transplant Infectious Disease - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/60cef806-94a8-4c06-b6df-d37c14c44bd3/tid14099-gra-0001-m.jpg)
Approach to patient reported outcome measures selection and implementation in a chronic norovirus clinical efficacy trial for patients after solid organ transplant - Keefer - 2023 - Transplant Infectious Disease - Wiley Online Library
![A New Era in Cardiac Rehabilitation Delivery: Research Gaps, Questions, Strategies, and Priorities | Circulation A New Era in Cardiac Rehabilitation Delivery: Research Gaps, Questions, Strategies, and Priorities | Circulation](https://www.ahajournals.org/cms/asset/4df9b9ed-f4b3-4ede-8d70-6a595aa117f2/circulationaha.122.061046.fig01.jpg)
A New Era in Cardiac Rehabilitation Delivery: Research Gaps, Questions, Strategies, and Priorities | Circulation
![The impact of patient-reported outcome (PRO) data from clinical trials: a systematic review and critical analysis | Health and Quality of Life Outcomes | Full Text The impact of patient-reported outcome (PRO) data from clinical trials: a systematic review and critical analysis | Health and Quality of Life Outcomes | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12955-019-1220-z/MediaObjects/12955_2019_1220_Fig2_HTML.png)
The impact of patient-reported outcome (PRO) data from clinical trials: a systematic review and critical analysis | Health and Quality of Life Outcomes | Full Text
![Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial - The Lancet Oncology Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial - The Lancet Oncology](https://www.thelancet.com/cms/asset/a3903ead-3066-41a8-9953-161d09384c00/gr1.jpg)
Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial - The Lancet Oncology
![The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders | Journal of Patient-Reported Outcomes | Full Text The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders | Journal of Patient-Reported Outcomes | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs41687-020-00219-4/MediaObjects/41687_2020_219_Fig1_HTML.png)
The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders | Journal of Patient-Reported Outcomes | Full Text
![Patient-Reported Experience and Outcome Measures in People Living with Diabetes: A Scoping Review of Instruments | The Patient - Patient-Centered Outcomes Research Patient-Reported Experience and Outcome Measures in People Living with Diabetes: A Scoping Review of Instruments | The Patient - Patient-Centered Outcomes Research](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40271-021-00526-y/MediaObjects/40271_2021_526_Fig1_HTML.png)
Patient-Reported Experience and Outcome Measures in People Living with Diabetes: A Scoping Review of Instruments | The Patient - Patient-Centered Outcomes Research
![The impact of patient-reported outcome (PRO) data from clinical trials: a systematic review and critical analysis | Health and Quality of Life Outcomes | Full Text The impact of patient-reported outcome (PRO) data from clinical trials: a systematic review and critical analysis | Health and Quality of Life Outcomes | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12955-019-1220-z/MediaObjects/12955_2019_1220_Fig3_HTML.png)
The impact of patient-reported outcome (PRO) data from clinical trials: a systematic review and critical analysis | Health and Quality of Life Outcomes | Full Text
![International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium - The Lancet Oncology International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium - The Lancet Oncology](https://www.thelancet.com/cms/asset/bb1e5429-30dd-4d84-ad6c-49f152b79cc3/gr1.jpg)